BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37589478)

  • 1. Development and validation of a nomogram for predicting osteoporosis in prostate cancer patients: A cross-sectional study from China.
    Wu S; Ma X; Liang Z; Jiang Y; Chen S; Sun G; Chen K; Liu R
    Prostate; 2023 Dec; 83(16):1537-1548. PubMed ID: 37589478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and validation of serum lipid-based nomogram for predicting the risk of prostate cancer.
    Feng F; Zhong YX; Chen Y; Lin FX; Huang JH; Mai Y; Zhao PP; Wei W; Zhu HC; Xu ZP
    BMC Urol; 2023 Jul; 23(1):120. PubMed ID: 37452418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constructing and validating a predictive nomogram for osteoporosis risk among Chinese single-center male population using the systemic immune-inflammation index.
    Zhuo H; Zhou Z; Chen X; Song Z; Shang Q; Huang H; Xiao Y; Wang X; Chen H; Yan X; Zhang P; Gong Y; Liu H; Liu Y; Wu Z; Liang D; Ren H; Jiang X
    Sci Rep; 2024 Jun; 14(1):12637. PubMed ID: 38825605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined multiple clinical characteristics for prediction of discordance in grade and stage in prostate cancer patients undergoing systematic biopsy and radical prostatectomy.
    Liu H; Tang K; Xia D; Peng E; Wang L; Chen Z
    Pathol Res Pract; 2020 Nov; 216(11):153235. PubMed ID: 33035728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter External Validation of a Nomogram for Predicting Positive Prostate-specific Membrane Antigen/Positron Emission Tomography Scan in Patients with Prostate Cancer Recurrence.
    Bianchi L; Castellucci P; Farolfi A; Droghetti M; Artigas C; Leite J; Corona P; Shagera QA; Moreira R; González C; Queiroz M; de Galiza Barbosa F; Schiavina R; Deandreis D; Fanti S; Ceci F
    Eur Urol Oncol; 2023 Feb; 6(1):41-48. PubMed ID: 34933814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of related factors for sarco-osteoporosis in middle-aged and elderly inpatients and development and validation of a nomogram.
    Juan Peng D; Gao FQ; Lou Y; Ma Y; Xia T
    BMC Musculoskelet Disord; 2024 Mar; 25(1):245. PubMed ID: 38539146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and validation of a novel predictive model to quantify the risk of bone metastasis in patients with prostate cancer.
    Lu YJ; Duan WM
    Transl Androl Urol; 2021 Jan; 10(1):310-325. PubMed ID: 33532320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An integrated nomogram combining deep learning, Prostate Imaging-Reporting and Data System (PI-RADS) scoring, and clinical variables for identification of clinically significant prostate cancer on biparametric MRI: a retrospective multicentre study.
    Hiremath A; Shiradkar R; Fu P; Mahran A; Rastinehad AR; Tewari A; Tirumani SH; Purysko A; Ponsky L; Madabhushi A
    Lancet Digit Health; 2021 Jul; 3(7):e445-e454. PubMed ID: 34167765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a nomogram including lymphocyte-to-monocyte ratio for initial prostate biopsy: a double-center retrospective study.
    Zhou ZH; Liu F; Wang WJ; Liu X; Sun LJ; Zhu Y; Ye DW; Zhang GM
    Asian J Androl; 2021; 23(1):41-46. PubMed ID: 32503957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a nomogram for predicting the probability of new vertebral compression fractures after vertebral augmentation of osteoporotic vertebral compression fractures.
    Li Q; Long X; Wang Y; Fang X; Guo D; Lv J; Hu X; Cai L
    BMC Musculoskelet Disord; 2021 Nov; 22(1):957. PubMed ID: 34784910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nomogram for predicting the biochemical recurrence of prostate cancer after neoadjuvant androgen deprivation therapy.
    Sun Q; Yang YZ; Yang P; Li YH; Cao Y; Chen D; Zhang Y
    Int Urol Nephrol; 2023 Sep; 55(9):2215-2224. PubMed ID: 37306931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter European external validation of a prostate health index-based nomogram for predicting prostate cancer at extended biopsy.
    Lughezzani G; Lazzeri M; Haese A; McNicholas T; de la Taille A; Buffi NM; Fossati N; Lista G; Larcher A; Abrate A; Mistretta A; Bini V; Palou Redorta J; Graefen M; Guazzoni G
    Eur Urol; 2014 Nov; 66(5):906-12. PubMed ID: 24361258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development and validation of a prognostic model for patients with sepsis in intensive care unit].
    Jiang Z; Wang H; Wang S; Guan C; Qu Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):800-806. PubMed ID: 37593856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Web-Based Prediction Model for Cancer-Specific Survival of Elderly Patients Undergoing Surgery With Prostate Cancer: A Population-Based Study.
    Zhang Z; Zhanghuang C; Wang J; Mi T; Liu J; Tian X; Jin L; He D
    Front Public Health; 2022; 10():935521. PubMed ID: 35903379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial prostate biopsy: development and internal validation of a biopsy-specific nomogram based on the prostate cancer antigen 3 assay.
    Hansen J; Auprich M; Ahyai SA; de la Taille A; van Poppel H; Marberger M; Stenzl A; Mulders PF; Huland H; Fisch M; Abbou CC; Schalken JA; Fradet Y; Marks LS; Ellis W; Partin AW; Pummer K; Graefen M; Haese A; Walz J; Briganti A; Shariat SF; Chun FK
    Eur Urol; 2013 Feb; 63(2):201-9. PubMed ID: 22854248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk stratification system and web-based nomogram constructed for predicting the overall survival of primary osteosarcoma patients after surgical resection.
    Gao B; Wang MD; Li Y; Huang F
    Front Public Health; 2022; 10():949500. PubMed ID: 35991065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nomogram based on peripheral lymphocyte for predicting 8-year survival in patients with prostate cancer: a single-center study using LASSO-cox regression.
    Chen J; Yu F; He G; Hao W; Hu W
    BMC Cancer; 2024 Feb; 24(1):254. PubMed ID: 38395827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nomograms and scoring system for forecasting overall and cancer-specific survival of patients with prostate cancer.
    Zhou Y; Lin C; Zhu L; Zhang R; Cheng L; Chang Y
    Cancer Med; 2023 Feb; 12(3):2600-2613. PubMed ID: 35993499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and external validation of a prostate health index-based nomogram for predicting prostate cancer.
    Zhu Y; Han CT; Zhang GM; Liu F; Ding Q; Xu JF; Vidal AC; Freedland SJ; Ng CF; Ye DW
    Sci Rep; 2015 Oct; 5():15341. PubMed ID: 26471350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and internal validation of a clinical prediction model for osteopenia in Chinese middle-aged and elderly men: a prospective cohort study.
    Li T; Zeng J; Pan Z; Hu F; Cai X; Wang X; Liu G; Hu X; Deng X; Gong M; Yang X; Gong Y; Li N; Li C
    BMC Musculoskelet Disord; 2024 May; 25(1):394. PubMed ID: 38769526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.